Market PerformanceRevenue growth improved to 16% from 11%, and US sales grew approximately 70% sequentially, beating consensus.
Product AdoptionThe high-volume plastic surgeon described a swift and substantial shift toward Motiva implants in his practice, now comprising the majority of usage in primary augmentation and revision cases, driven by the product’s superior tactile feel, natural appearance, and patient preference.
Product InnovationESTA's innovative portfolio featuring best-in-class data and leveraging multiple demand trends is poised to take considerable share in the US market as its domestic launch continues and as it submits more of its products/indications to the FDA.